Corrigendum to "Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment" [Immunol. Lett. 121 (2008) 105-109] (DOI:10.1016/j.imlet.2008.09.004);Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment

Immunology Letters

Volumn 121, Issue 2, 2008, Pages 105-109

  Lee, Kang Soo ^a   Chung, Ji Hyung ^b   Lee, Kyung Hye ^b   Shin, Min Jeong ^c   Oh, Byoung Hoon ^a   Hong, Chang Hyung ^d,e  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yeungnam University   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e Ajou University Medical Center   (South Korea)

Author keywords

Alzheimer's disease; Bioplex; Cytokine; Macrophage migration inhibitory factor; Mild cognitive impairment; Monokine induced by interferon

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MACROPHAGE MIGRATION; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 57449093991     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.02.007     Document Type: Erratum

References (26)

1. Wilson C.J., Finch C.E., and Cohen H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50 (2002) 2041-2056
2. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 8 (1998) 65-72
3. Raine C.S. Inflammation in Alzheimer's disease: a view from the periphery. Neurobiol Aging 21 (2000) 437-440
4. Bermejo P., Martin-Aragon S., Benedi J., Susin C., Felici E., Gil P., et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 117 (2008) 198-202
5. Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., et al. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63 (2006) 538-543
6. Galimberti D., Schoonenboom N., Scarpini E., Scheltens P., and On behalf of the Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol 53 (2003) 547-548
7. Rentzos M., Paraskevas G.P., Kapaki E., Nikolaou C., Zoga M., Rombos A., et al. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J Neurol Sci 249 (2006) 110-114
8. Rentzos M., Zoga M., Paraskevas G.P., Kapaki E., Rombos A., Nikolaou C., et al. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J Geriatr Psychiatry Neurol 19 (2006) 114-117
9. Blasko I., Lederer W., Oberbauer H., Walch T., Kemmler G., Hinterhuber H., et al. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 21 (2006) 9-15
10. Singh V.K., and Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res 31 (1997) 657-660
11. Lombardi V.R., Garcia M., Rey L., and Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease (AD) individuals. J Neuroimmunol 97 (1999) 163-171
12. Angelis P., Scharf S., Mander A., Vajda F., and Christophidis N. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. Neurosci Lett 244 (1998) 106-108
13. van Duijn C.M., Hofman A., and Nagelkerken L. Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease. Neurosci Lett 108 (1990) 350-354
14. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C., et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J Neuroimmunol 103 (2000) 97-102
15. Leblhuber F., Walli J., Demel U., Tilz G.P., Widner B., and Fuchs D. Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin Chem Lab Med 37 (1999) 429-431
16. Fulton R.J., McDade R.L., Smith P.L., Kienker L.J., and Kettman Jr. J.R. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43 (1997) 1749-1756
17. de Jager W., te Velthuis H., Prakken B.J., Kuis W., and Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10 (2003) 133-139
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
19. Nishihira J. Novel pathophysiological aspects of macrophage migration inhibitory factor. Int J Mol Med 2 (1998) 17-28
20. Oyama R., Yamamoto H., and Titani K. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Biochim Biophys Acta 1479 (2000) 91-102
21. Degryse B., and de Virgilio M. The nuclear protein HMGB1, a new kind of chemokine?. FEBS Lett 553 (2003) 11-17
22. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13 (2007) 587-596
23. Ghersa P., Gelati M., Colinge J., Feger G., Power C., Papoian R., et al. MIG-differential gene expression in mouse brain endothelial cells. Neuroreport 13 (2002) 9-14
24. Xia M.Q., Bacskai B.J., Knowles R.B., Qin S.X., and Hyman B.T. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108 (2000) 227-235
25. Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Venturelli E., Pijnenburg Y.A., et al. Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology 66 (2006) 146-147
26. Baron P., Bussini S., Cardin V., Corbo M., Conti G., Galimberti D., et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32 (2005) 541-544